NZ246677A

NZ246677A - Preparatory process for 2-amino-6-chloropurine

Info

Publication number: NZ246677A
Application number: NZ246677A
Authority: NZ
Inventors: Christopher Robert Jame Killen
Original assignee: Smithkline Beecham Plc
Priority date: 1992-01-30
Filing date: 1993-01-28
Publication date: 1996-02-27
Also published as: EP0625154A1; AU669874B2; AU3365493A; ZA93615B; GB9201961D0; CA2117435A1; KR950700299A; JPH07503246A; WO1993015075A1; MX9300482A

Description

<div class="application article clearfix" id="description"> New Zealand Paient Spedficaiion for Paient Number £46677 24 6 6 7 7 New Zealand No. 246677 International No. PCT/GB93/00185 TO BE ENTERED AFTER ACCEPTANCE AND PUBLICATION Priority dates; 2><=> \ \ \ R *3. Intemational fifing date: 28) I) <33> Classification:; ?cL>\ Cci id un 2>/ M-O. Publication date: 2 7 FEB 1996 Journal No.: , i i ^ . NEWZE^IAKD PATENTS ACT 1953 • COMPLETE SPECIFICATION Tide of invention: PREPARATION OF 2-AMINO-6-CHLOROPURINE Name, address and nationality of applicant(s) as in international application fonn: SMITHKLINE BEECHAM pic, a British company of New Horizons Court, Brentford, Middlesex TW8 9EP, United Kingdom. WO 93/15075 246 67 7 PCT/GB93/00185 -1- Preparation of 2-am1no-6-chloropur1ne This invention relates to a process for the preparation of a compound useful 5 as an intermediate in the preparation of pharmaceutical compounds. The compound 2-amino-6-chloropurine of formula (I): CI is a useful intermediate in the preparation of nucleoside analogue antiviral agents, such as penciclovir and famciclovir, described in EP-A-141927 (Example 1) and EP-A-182024 (Example 2). The intermediate is 15 9-substituted with an appropriate side chain precursor, followed by conversion of the 6-chloro moiety to a hydroxy (a guanine) or hydrogen (a 2-aminopurine). EP-A-203685 (Beecham Group p.l.c.) describes a process for preparing a 20 compound of formula (I) as hereinbefore defined, which process comprises reacting guanine with a chlorinating agent in the presence of a phase transfer catalyst containing chloride ions. EP-A-433846 (Hoechst Aktiengesellschaft) describes a corresponding process for preparing the 2-acylated derivative, involving chlorination of 2,9-diacylguanine and subsequent removal of the 9-25 acyl group by hydrolysis. The reaction is preferably carried out in a polar inert organic solvent such as acetonitrile.tetrahydrofuran, dioxan, nitromethane, diglyme, dimethoxyethane, or dichloromethane. Acetonitrile is highly preferred. 30 246677 O 93/15075 PCT/GB93/00185 -2- Suitable phase transfer catalysts include tetrasubstituted ammonium chlorides. Examples of ammonium substituents include C2-12 a'kytf usually C2-4 alkyl, or phenyl or benzyl. Other possible phase transfer catalysts include tetra-substituted phosphonium chlorides wherein examples of the 5 substitutents are as defined above for ammonium chlorides. Preferably the phase transfer catalyst is tot. aethylammonium chloride. The phase-transfer catalyst is preferably present in an amount of from 1 to 3 equivalents of the compound of formula (II) and preferably from 1 to 2 10 equivalents. A preferred chlorinating agent is phosphorus oxychloride. Preferably the chlorinating agent is present in an amount of from 2-10 15 preferably from 3-6 molar equivalents of the guanine derivative. The reaction may be effected in the presence of a weak base, such as a tertiary amine, for example N,N-dimethylaniline or diethylamide or triethylamine. The base is usually present in an approximately molar 20 equivalent amount with respect to the guanine derivative. Alternatively, a catalytic amount of water may be added to the reaction mixture. When acetonitrile is the solvent, added base may not be necessary, but is preferred. 25 The reaction is preferably carried out at an elevated temperature of from 30-100°C, most preferably under reflux and/or with ultrasonication at 50-70°C. Preferably the reaction is allowed to proceed for a period of greater than half 30 an hour, usually less than 30 hours. We have now discovered that the compound of formula (I) may be prepared from 2,9-diacyiguanine. </div>

Claims

<div class="application article clearfix printTableText" id="claims"> 24 8 6 7 7 -3- Accordingly, the present invention provides a process for preparing 2-amino-W 6-chloropurine, which process comprises reacting a 2,9-diacylated derivative of guanine with a chlorinating agent in the presence of a phase transfer catalyst containing chloride ions, and thereafter removing the 9-acyl group 5 and the 2-acyl group by hydrolysis. The reaction is described in EP-A-203685 and EP-A-433846, which are incorporated herein by reference, except that methyttriethylammonium chloride is a preferred phase transfer catalyst; the amount of phosphorus 10 oxychloride may be reduced to 2-4 equivalents, and the reaction time can be reduced. The removal of the 9-acyl group generally occurs at ambient temperature (below 30°C), but higher temperatures and reaction times (80-100°C, 1-2 15 hours) are needed for removal of the 2-acyl group. Aqueous sodium hydroxide is a suitable basic medium for the hydrolysis. 20 The following example illustrates the invention. Example Diacetyl guanine (8.0g, 0.034 moles), triethylmethyiammonium chioride (15.45g, 0.102 moles), and triethylamine (4.74 mis, 0.034 moles) were 25 heated together with stirring in acetonitrile (70mls) to 50°C. Phosphorus oxychloride (6.34 mis, 0.068 moles) was then added and stirring continued for 4 hours. The reaction mixture was cooled and then added to aqueous sodium hydroxide solution (20g in 300mls water). The reaction mixture was heated to 80°C for 2 hours and then the volume made up to 300 mis with 30 water. The mixture was cooled to 25°C and the pH adjuster to 7 using 10% hydrochloric acid. The resulting slurry was stirred for fifteen minutes and the product filtered off and washed with water 30 mis and then dried at 80°C under vacuum to give a cream/off white coloured product. ; * * £ f, 35 Weight 2-amino-6-chloropurine 4.69 g (74.6% yield). -4- 246677 WHAT WE CLAIM IS:

1. A process for preparing 2-amino-6-chloropurine, which process comprises reacting a 2,9-diacylated derivative of guanine with a chlorinating agent in the presence of a phase transfer catalyst containing chloride ions, and thereafter removing the 9-acyl group and the 2-acyl group by hydrolysis.

2. A process according to claim 1, wherein the chlorinating agent is phosphorus oxychloride and the phase transfer catalyst is methyltriethylammonium chloride.

3. A process according to claim 2, wherein the amount of phosphorus oxychloride is 2-4 equivalents with respect to the 2,9-acylated guanine.

4. A process according to any one of claims 1 to 3, wherein aqueous sodium hydroxide is used as a basic medium for the hydrolysis.

5. Famciclovir or penciclovir whenever prepared from 2-amino-6-chloropurine prepared by the process of any one of claims 1 to 4.

6. A process according to claim 1, substantially as described herein with reference to the Example.

7. 2-Amino-6-chloropurine whenever prepared according to the process of any one of claims 1 to 4. . By the authorised agents A J PARK & S </div>